Challenges and perspectives of selenium supplementation in Graves' disease and orbitopathy.

Published in: Hormones (Athens, Greece) (2019)

Additional randomized clinical trials with clinically relevant endpoints are urgently needed to further aid in clinical decision-making, including better stratification of Graves' disease patients, who are most likely to benefit from Se supplementation.

Keyphrases

decision making
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
clinical trial